Serina Therapeutics (SER) Accumulated Depreciation & Amortization (2017 - 2025)
Serina Therapeutics (SER) has disclosed Accumulated Depreciation & Amortization for 8 consecutive years, with $100000.0 as the latest value for Q4 2025.
- Quarterly Accumulated Depreciation & Amortization changed 0.0% to $100000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $100000.0 through Dec 2025, changed 0.0% year-over-year, with the annual reading at $100000.0 for FY2025, 0.0% changed from the prior year.
- Accumulated Depreciation & Amortization hit $100000.0 in Q4 2025 for Serina Therapeutics, down from $650000.0 in the prior quarter.
- In the past five years, Accumulated Depreciation & Amortization ranged from a high of $650000.0 in Q3 2025 to a low of $100000.0 in Q4 2024.
- Historically, Accumulated Depreciation & Amortization has averaged $403000.0 across 4 years, with a median of $425000.0 in 2024.
- Biggest five-year swings in Accumulated Depreciation & Amortization: tumbled 74.36% in 2024 and later soared 49.64% in 2025.
- Year by year, Accumulated Depreciation & Amortization stood at $227000.0 in 2021, then soared by 71.81% to $390000.0 in 2023, then crashed by 74.36% to $100000.0 in 2024, then changed by 0.0% to $100000.0 in 2025.
- Business Quant data shows Accumulated Depreciation & Amortization for SER at $100000.0 in Q4 2025, $650000.0 in Q3 2025, and $634000.0 in Q2 2025.